4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001231589-26-000002
EVP & GENERAL COUNSEL sold 8,300 shares at an average $469.89 ($3,900,122)
- EVP & GENERAL COUNSEL acquired 8,300 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
MAHON PAUL A · EVP & GENERAL COUNSEL
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,300 | $146.03 | $1,212,049 | 45,081 | D |
| 2026-01-15 | Sale : show line 2 in the form 10b5-1 | −1,439 | $468.32 | $673,918 | 43,642 | D |
| 2026-01-15 | Sale : show line 3 in the form 10b5-1 | −1,307 | $470.37 | $614,769 | 42,335 | D |
| 2026-01-15 | Sale : show line 4 in the form 10b5-1 | −407 | $472.28 | $192,219 | 41,928 | D |
| 2026-01-15 | Sale : show line 5 in the form 10b5-1 | −3,531 | $469.34 | $1,657,237 | 38,397 | D |
| 2026-01-15 | Sale : show line 6 in the form 10b5-1 | −1,576 | $471.44 | $742,990 | 36,821 | D |
| 2026-01-15 | Sale : show line 7 in the form 10b5-1 | −40 | $474.74 | $18,990 | 36,781 | D |
| Open-market sales · 8,300 sh · avg $469.89 · $3,900,122 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-15 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option | −8,300 | 58,400 | D |
Loading xslF345X05/primarydocument.xml…